New pill hopes to fight advanced cancers when other treatments fail
Disease control
Recruiting now
This early-stage trial tests an experimental oral drug called EP102 in people with advanced solid tumors who have no other treatment options. The main goals are to find the safest dose and understand side effects. About 48 participants with specific cancer types will take the dru…
Phase: PHASE1 • Sponsor: Epics Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC